Margarita Chavez Buys Shares of ALGS
Margarita Chavez purchased 5,860 shares of ALGS on June 25, 2026.
Key Points
- Margarita Chavez bought 5,860 shares of ALGS on June 25, 2026, with no disclosed transaction price.
- Shares of ALGS traded near $5.57 on Tuesday, with institutional investors like Bank of America Corp significantly increasing their holdings.
- Analysts from Lake Street and Cantor Fitzgerald initiated 'buy' ratings with targets of $45 and $20, respectively.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Margarita Chavez, an insider at ALGS, recently bought 5,860 shares of the company on June 25, 2026. The transaction didn't have a disclosed price, and it wasn't part of a pre-planned trading program.
Insider Buying and Selling at Aligos Therapeutics, Inc.
On June 25, 2026, several insiders at ALGS, including Carole Nuechterlein, Margarita Chavez, Peter Hirth, Heather Preston, Bridget Martell, and James Paul Scopa, each acquired 5,860 shares. These transactions were not conducted under Rule 10b5-1 trading plans.
Other Institutional Activity in ALGS
Bank of America Corp substantially increased its position in ALGS, adding 216,646 shares to hold a total of 229,754 shares valued at about $1.71 million. Meanwhile, Vanguard Capital Management LLC opened a new position with 178,262 shares worth approximately $1.32 million. On the other hand, SIO Capital Management, LLC reduced its holdings by 8,700 shares, bringing its total to 327,237 shares valued at $2.43 million.
Aligos Therapeutics, Inc. Stock Down 21.4%
Shares of ALGS traded near $5.57 on Tuesday. The company has attracted attention from institutional investors and analysts alike, with recent trades reflecting diverse strategies among major funds.
$ALGS stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On May 28, 2026, Lake Street initiated coverage on ALGS with a 'buy' rating and a $45 price target. A week earlier, on May 21, Cantor Fitzgerald also started coverage with a 'buy' rating and a $20 target. Additionally, WestPark Capital and Jefferies both initiated 'buy' ratings in March with targets of $48.
About ALGS
ALGS is a company primarily engaged in [describe business operations in a simple way]. The company is headquartered in [city, state], and it operates within the [sector/industry]. [Any additional information about leadership or employees if available].
Bottom Line
Margarita Chavez's recent purchase of ALGS shares is part of a broader pattern of insider buying at the company. Investors should note that this insider activity was not part of any pre-planned trading program. Institutional investors have shown varied strategies, with some increasing and others decreasing their stakes. Analysts have been optimistic, with several 'buy' ratings and price targets suggesting potential growth. As always, remember that insider and institutional activity is backward-looking and may not reflect current positions.
Get Aligos Therapeutics, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ALGS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.